GNB3 and Hypertension: Interactions between genetic variants of FTO and GNB3 influence clinical parameters to augment hypertension, probably by modulating the FTO expression in metabolically relevant tissues such as the hypothalamus and affecting the subsequent translation of key signaling molecules such as GNB3 [32].